These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 21679375

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Discovery of new renin inhibitory leads via sequential pharmacophore modeling, QSAR analysis, in silico screening and in vitro evaluation.
    Al-Nadaf AH, Taha MO.
    J Mol Graph Model; 2011 Apr; 29(6):843-64. PubMed ID: 21376648
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.
    Taha MO, Atallah N, Al-Bakri AG, Paradis-Bleau C, Zalloum H, Younis KS, Levesque RC.
    Bioorg Med Chem; 2008 Feb 01; 16(3):1218-35. PubMed ID: 17988876
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discovery of DPP IV inhibitors by pharmacophore modeling and QSAR analysis followed by in silico screening.
    Al-Masri IM, Mohammad MK, Taha MO.
    ChemMedChem; 2008 Nov 01; 3(11):1763-79. PubMed ID: 18989859
    [Abstract] [Full Text] [Related]

  • 8. Pharmacophore and QSAR modeling of estrogen receptor beta ligands and subsequent validation and in silico search for new hits.
    Taha MO, Tarairah M, Zalloum H, Abu-Sheikha G.
    J Mol Graph Model; 2010 Jan 01; 28(5):383-400. PubMed ID: 19850503
    [Abstract] [Full Text] [Related]

  • 9. Discovery of new potent human protein tyrosine phosphatase inhibitors via pharmacophore and QSAR analysis followed by in silico screening.
    Taha MO, Bustanji Y, Al-Bakri AG, Yousef AM, Zalloum WA, Al-Masri IM, Atallah N.
    J Mol Graph Model; 2007 Mar 01; 25(6):870-84. PubMed ID: 17035054
    [Abstract] [Full Text] [Related]

  • 10. Docking-based comparative intermolecular contacts analysis as new 3-D QSAR concept for validating docking studies and in silico screening: NMT and GP inhibitors as case studies.
    Taha MO, Habash M, Al-Hadidi Z, Al-Bakri A, Younis K, Sisan S.
    J Chem Inf Model; 2011 Mar 28; 51(3):647-69. PubMed ID: 21370899
    [Abstract] [Full Text] [Related]

  • 11. Elaborate ligand-based modeling coupled with multiple linear regression and k nearest neighbor QSAR analyses unveiled new nanomolar mTOR inhibitors.
    Khanfar MA, Taha MO.
    J Chem Inf Model; 2013 Oct 28; 53(10):2587-612. PubMed ID: 24050502
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B, Freeman SK, Zupec ME, Lu HF, Nagarajan SR, Kishore NS, Lodge JK, Kuneman DW, McWherter CA, Vinjamoori DV, Getman DP, Gordon JI, Sikorski JA.
    J Med Chem; 1997 Aug 01; 40(16):2609-25. PubMed ID: 9258368
    [Abstract] [Full Text] [Related]

  • 13. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
    Liu J, Pan D, Tseng Y, Hopfinger AJ.
    J Chem Inf Comput Sci; 2003 Aug 01; 43(6):2170-9. PubMed ID: 14632469
    [Abstract] [Full Text] [Related]

  • 14. Elaborate ligand-based modeling reveals new nanomolar heat shock protein 90α inhibitors.
    Al-Sha'er MA, Taha MO.
    J Chem Inf Model; 2010 Sep 27; 50(9):1706-23. PubMed ID: 20831219
    [Abstract] [Full Text] [Related]

  • 15. Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors.
    Khanfar MA, Taha MO.
    J Mol Recognit; 2017 Sep 27; 30(9):. PubMed ID: 28299833
    [Abstract] [Full Text] [Related]

  • 16. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
    Abu Hammad AM, Taha MO.
    J Chem Inf Model; 2009 Apr 27; 49(4):978-96. PubMed ID: 19341295
    [Abstract] [Full Text] [Related]

  • 17. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ.
    J Chem Inf Model; 2009 Apr 27; 49(4):1070-8. PubMed ID: 19296716
    [Abstract] [Full Text] [Related]

  • 18. Ligand-based modeling of diverse aryalkylamines yields new potent P-glycoprotein inhibitors.
    AlQudah DA, Zihlif MA, Taha MO.
    Eur J Med Chem; 2016 Mar 03; 110():204-23. PubMed ID: 26840362
    [Abstract] [Full Text] [Related]

  • 19. Elaborate ligand-based pharmacophore exploration and QSAR analysis guide the synthesis of novel pyridinium-based potent beta-secretase inhibitory leads.
    Al-Nadaf A, Abu Sheikha G, Taha MO.
    Bioorg Med Chem; 2010 May 01; 18(9):3088-115. PubMed ID: 20378363
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.
    Sheng C, Xu H, Wang W, Cao Y, Dong G, Wang S, Che X, Ji H, Miao Z, Yao J, Zhang W.
    Eur J Med Chem; 2010 Sep 01; 45(9):3531-40. PubMed ID: 20615585
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.